In an attempt to identify genes that control or encode the targets of general anesthetics, we have chemically mutagenized fruit flies and selected four lines that show an abnormal response to the volatile anesthetic halothane. Specifically, about 2-fold higher concentrations of halothane are required to induce the loss of motor control in the mutant flies. Fine mapping of two isolates indicates that they alter a previously uncharacterized gene of Drosophila. In the absence of anesthetics, these mutants display alterations of behavior that imply changes in the adult and the larval neuromuscular system.
The mechanism by which anesthetics cause their typical response-loss of consciousness and insensitivity to painremains speculative (1, 2) . Many plausible subcellular targets for anesthetics have been proposed (3) (4) (5) (6) (7) (8) but it has been difficult to choose among these candidates since each is supported by evidence of modification by anesthetics. Similarly, when one seeks to understand the chemical basis of anesthetic action, it is hard to choose between theories that call for the direct effect of anesthetics on a receptor or channel and theories in which the function of the putative target is altered only as a secondary consequence of an anesthetic-induced alteration in the lipid portion of cell membranes (9) (10) (11) . One useful resource to help distinguish between proposed mechanisms for anesthesia would be a collection of mutants that were each altered in their responsiveness to anesthetics; the collection would be particularly useful if each mutant affected only a single genetic locus. The ability to isolate such mutants would imply not only that the components are under genetic control but also that there are only a limited number of ways that anesthetics induce their effects. Moreover, among such mutants should be some that are altered in the abundance or properties of the anesthetic target(s). These mutants might therefore provide useful material for biochemical tests of particular theories of anesthesia. In addition, molecular genetic techniques might permit the identification of a component that is required for anesthesia even in the absence of an a priori hypothesis. It should also be pointed out that such a mutant collection might well identify interesting and novel components of the nervous system even if their involvement in the anesthetic response is only indirect.
In this work we have tested the feasibility of obtaining mutants ofDrosophila melanogaster that change its response to anesthetics. Drosophila has been long known to be reversibly anesthetized-i.e., rendered motionless and unresponsive to stimuli-by the classical anesthetic diethyl ether (12) . Fruit flies are also sensitive to the nonflammable volatile anesthetic halothane (CF3CHClBr) and we used this agent in our initial experiments. We have restricted our genetic study to the induction phase of anesthesia-i.e., the process of losing consciousness. In this way we tried to concentrate on the neural response to halothane and bias against alterations that affect only the metabolism or distribution of the drug (which we reasoned might be more prominent among mutants affected in the recovery from an anesthetic dose). Moreover, we have not attempted to isolate sensitive mutants but have limited our screen to mutants resistant to halothane. This was done in the hope of avoiding genetic changes that simply weaken the fly and thereby make it nonspecifically sensitive to an insult. To simplify the labor involved in the search for mutants, we used well-established procedures (13, 14) for crossing males that had been fed a chemical mutagen with females whose X chromosomes are attached. This allowed us to examine the offspring en masse not only for dominant mutations but for recessive X chromosome-linked mutations that were transmitted directly from fathers to sons. From about 20,000 chemically mutagenized flies we have identified four resistant mutants and herein report their initial characterization.
MATERIALS AND METHODS
Fly Stocks and Genetic Methods. The wild-type strain OreR was obtained from R. Greenspan (Roche Institute of Molecular Biology, Nutley, NJ). The attached-X stock C(1)DX y f and the X chromosome balancer MS were from S. Haynes (National Institute of Child Health and Human Development). The mapping stock y Wa ct gfbalanced with FM7a was from J. Kennison (National Institute of Child Health and Human Development). Df(1)RK2, Df(J)RKS, and DJ (1)rDJ7 were from the laboratory of B. Ganetzky (University of Wisconsin). All other stocks were from the Bloomington Stock Center (Bloomington, IN).
Flies were grown in cornmeal molasses agar at 220C.
Chemical mutagenesis with ethyl methanesulfonate was performed as described by Lewis and Bacher (13) ; treated OreR males were mated to attached-X females for 1-2 days and the F1 generation was screened for anesthesia resistance. The resistant alleles so identified have been maintained for >1 year as hemizygous lines with attached-X females, as homozygous lines, and as heterozygous lines with the MS balancer; with routine precautions, the phenotype of each line has remained stable.
Behavioral Assays. Column fractionation of flies was performed in an "inebriometer", which was constructed essentially as described (15) . For screening mutagenized populations, 500-1000 flies were loaded in one run and exposed to halothane (Halocarbon Laboratories, North Augusta, SC). The anesthetic was delivered (6 liters/min) using a Penlon evaporator and compressed air; concentration was set at 0.5% and checked with a Riken model 18 gas indicator. After 30-45 min, the flies remaining in the column were collected *On leave from Tata Institute of Fundamental Research, Bombay.
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by flushing the column with 100o CO2. For anesthesia testing of individual lines, flies were between 1 and 4 days old posteclosion; they were sorted under CO2 anesthesia and kept for 1 day on fresh medium prior to testing. Typically, 20-100 flies of a particular genotype were loaded onto the column, usually together with an equal or larger number of flies that were morphologically distinct, and exposed to halothane as above; flies were collected every 2 min.
For visual inspection of the response to anesthetics, a "separator" chamber was used. This device consists of a 200-ml egg-shaped glass enclosure (made from a separator flask) that can be connected to a cylindrical glass chamber below it. Groups of 10-12 flies were introduced into the upper chamber and, after connecting the two components, the system was perfused with anesthetic at a flow rate of 6 liters/min. Flies were observed in the lower chamber with the help of a hand lens; those that were lying on their backs on the base of this chamber were counted as anesthetized.
The motor activity of adult flies was assessed with a "monitor". The device consists of a borosilicate tube (diameter = 13 mm; length = 75 mm) fitted with two photodetectors and two infrared photodiodes. About 10 flies were introduced into the tube, which was then placed in a dark chamber. Movement of the flies creates a signal in the photodiode; the number of such spikes that accumulate in a standard time interval (usually 60 sec) was printed as the output of a microprocessor. Typically, a group of 10 flies produced 250-300 spikes per min. The chamber was perfused at 1 liter/min with anesthetic and the time required to have three consecutive intervals with no spikes was noted.
RESULTS
Isolation of Halothane-Resistant (har) Mutants. We reasoned that because anesthetics may interact with critical components of the nervous system it might not be possible to obtain viable flies that have radical alterations in anesthetic sensitivity. Accordingly, we screened mutagenized stocks of flies with an apparatus designed to detect subtle differences in fly behavior. An inebriometer, designed by Weber (15) to assess alcohol resistance in natural populations of flies, consists of a glass column containing about 20 nylon mesh baffles on which flies can rest. When exposed to an anesthetic such as halothane, flies tend to fall off the baffles but have repeated opportunities to settle on a baffle that is lower in the column. We screened for flies that eluted from the column at late times, thereby enriching for flies that had not suffered the loss of motor control that typifies anesthesia. After cycling 20 The proportion of flies eluted from the column after 30 min of exposure to 0.5% halothane is shown. The data are averages (±SD) of n experiments. again through the inebriometer, candidate male flies were used to establish separate lines with attached-X females. In all, we screened about 20,000 mutagenized flies, tested about 100 individual lines, and recovered four mutants. Fig. 1 presents inebriometer elution profiles of wild-type flies and the four halothane-resistant mutant lines (har mutants). Although the graph of Fig. 1 shows results from a single experiment for each line, several repetitions yielded comparable results. As shown in Table 1 , on average the mutants are 1.5 (har56) to 7.9 (har38) less responsive than control flies in this test.
To observe the behavior of the mutants more closely, we exposed groups of about 10 male flies of each line to different concentrations of halothane in a glass enclosure (separator) that contained no baffles. To measure the anesthetic response we simply scored how many flies were lying motionless on their backs at the bottom of the vessel after a given time (Fig.  2) . The results support the interpretation of the inebriometer tests; mutant lines appear to be more resistant than the wild-type line in their response to halothane. This is especially clear at L.0o and 1.5% halothane, where each mutant line is significantly different (95% by Scheffe's F test) from OreR. From the shift in the concentration of halothane required to render half of the flies anesthetized in 5 min, it appears that the mutants are 1.5-2.5 times as resistant as their wild-type counterparts.
Genetic Characterization of the Mutants. When mutant male flies are maintained as stocks with nonresistant females whose X chromosomes are attached, all male progeny and no female progeny show halothane resistance. This indicates that each of the har mutations maps to the X chromosome. To determine the behavior of the har alleles in the presence of another X chromosome, we crossed mutant males to normal females and established homozygous and heterozygous stocks. Females homozygous for three har mutants are readily distinguished from wild-type flies (Table 2) . How- Genetics: Krishnan and Nash
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Genetics: Krishnan and Nash females of the indicated har genotype were exposed to 2.0o halothane in the separator assay. The fraction (±SD) of flies (from n experiments) that are scored as anesthetized after 5 min is reported. The wild-type X chromosome in these experiments was the M5 balancer.
ever, har56 homozygotes cannot be reliably distinguished from wild-type flies in this test. To determine the dominant or recessive character of the remaining mutants, heterozygotes containing an X chromosome from a har strain and a wild-type X chromosome were tested in the separator assay. According to these tests (Table 2) , har63 is a dominant mutation (and will be henceforth referred to as Har63), whereas har38 and har85 are recessive.
Because har38 and har85 show the most resistance to anesthesia, and are therefore easiest to study, we undertook the genetic mapping of these alleles. We first located the har85 allele by meiotic recombination with several easily scored markers-w, ct, g, and f-that divide the X chromosome into roughly equal intervals. Tests of anesthesia resistance in recombinant lines indicated that har85 maps to the g-f interval. All of 12 lines that had inherited this segment from the nonresistant parent but had a crossover in the w-ct or ct-g intervals were sensitive to halothane. However, 2 of 6 lines that had a crossover in the g-f interval displayed resistance. (14) . This is largely because they tend to walk by fits and starts, taking a few steps and then stopping before starting again. Mechanical shock such as banging enhances the hesitancy of these flies; however, given a long enough time they display a pronounced negative geotaxis. All of the above traits-low viability, hesitant walking, and abdominal morphology-map to the same deficiencies that uncover the anesthesia resistance behavior. Larvae of har38 and har85 also show unusual behavior in the absence of anesthetics. In the phototaxis assay of Lilly and Carlson (16) , third instar larvae of these mutants migrate less markedly from well-lit sectors to dark sectors in the time allotted (response index of 0.19 compared to 0.68 for wild-type larvae). The larvae are clearly mobile; we do not know if their phototaxis defect represents failure to sense light, sluggish mobility, or indifference to illumination. Taken together, our data convince us that the phenotype of mutants har38 and har85 does not depend solely on a pharmacological challenge. These flies have suffered alterations in physiology, presumably reflecting changes in the neuromuscular system, that render them atypical in their response to anesthetics.
The way in which these mutants respond to anesthetics provides some clue as to the nature of the change in the nervous system. When exposed to anesthetics, individuals of the har38 and har85 strains tend to become immobile. This has been quantitated with an activity monitor. On exposure to 1.5% halothane, wild-type flies take 4.9 ± 1.6 min to cease activity, whereas har38 and har85 become inactive after only 2.0 ± 1.1 min and 1. Genetics: Krishnan and Nash clinically useful volatile anesthetics; not only do all succeed in anesthetizing the flies but also the relative potency of these compounds agrees well with published values for anesthesia in humans (K.S.K., D. B. Campbell, and H.A.N., unpublished observations). It should be emphasized that the anesthetic effects in Drosophila are reversible. We have kept flies asleep with 1% halothane for 16 hr; if one takes precaution against dehydration, at least half of these flies recover after removal of the anesthetic. Another feature of anesthesia in flies that is reminiscent of the behavior in higher organisms is the progressive loss of neural functions with increasing dose of the anesthetic agent (20) . In summary, despite differences in the anatomy of their respective nervous systems, the chemistry and physiology of anesthesia in flies closely parallel that observed in vertebrates.
Although limited, our current set of mutants provides some interesting leads. We have tested our mutants with six additional anesthetics and we find that each mutant shows cross-resistance to some but not all of these agents (K.S.K., D. B. Campbell, and H.A.N., unpublished observations). Thus, our mutants are not halothane specific. Other evidence makes it clear that at least mutants har38 and har85 change the fly's behavior in the absence of anesthetics. Adults of these strains have an altered pattern of walking and larvae show defects in light-evoked movement. These phenotypes point to an alteration in the nervous system that presumably underlies their altered response to anesthetics. Although all of our mutants were selected as resistant to anesthetics, we suspect that the tendency of har38 and har85 to become immobile in response to halothane implies that their nervous system is actually sensitive to this agent but responds to it in an unorthodox way. Nevertheless, it should be emphasized that the mutants har38 and har85 define at least one gene that has not been previously characterized as a locus affecting behavior in Drosophila. The deficiency mapping of Table 3 and Fig. 3 locates the gene(s) of these alleles to the 12E1-E9 region. Although several previously described neurological mutants map nearby, the complementation pattern of these mutants with deficiencies in the region is clearly different from that observed with har38 and har85. Our experience with these two mutants convinces us that mutations isolated as halothane resistant in the inebriometer, in addition to their utility in exploring the basis of anesthesia, may also be valuable for uncovering genetic elements of the nervous system.
There have been previous efforts to use genetic methods to gain insight into the mechanism of anesthetics. For example, colonies of mice have been bred selectively for an altered response to nitrous oxide (21) . However, the genetic complexity underlying the phenotype of the resistant and sensitive colonies made it difficult to pursue genetic studies. An organism with much more tractable genetics, the roundworm Caenorhabditis elegans, has also been examined for the anesthetic response (22) . Here, single locus mutants were identified that render C. elegans abnormally sensitive to some but not all anesthetics (23, 24) . It is too early to speculate on the relationship between the C. elegans mutants and those that we have obtained in D. melanogaster. However, we note that the nervous system ofDrosophila contains tens of thousands of neurons, whereas C. elegans has only 302 nerve cells. Accordingly, we suspect that in Drosophila, anesthetics may have the opportunity to depress the kind of subtle targets that are found in more complex nervous systems of higher organisms. In keeping with this idea, it should be pointed out that much higher concentrations of halothane (ED50 = 3.2%) are required to render C. elegans immobile (22) than are required to anesthetize D. melanogaster (ED50 '1.0%O; see Fig. 2 ).
Most previous work with Drosophila genetics and anesthesia has involved diethyl ether. The mutants Shaker, Hyperkinetic, and ether-a-go-go display violent motion upon etherization (25) and various ether-sensitive strains that die after exposure have been described (26, 27) . In addition, Eth29, a strain resistant to the lethal effects of high concentrations of ether, has been described (28); this strain was found to be resistant to the induction of anesthesia by several agents (29) . It will be of interest to compare these strains with those that we have isolated. One obvious difference is that Eth29, apparently a natural isolate and not the result of a mutagenesis, contains multiple changes that map to different chromosomes. Royden (30) has found that technical knockout (tko) wakes from ether anesthesia more promptly than do wild-type flies. This mutation, which has a bang-sensitive phenotype, maps near the white locus (31) and therefore represents a gene not included among mutants that we have mapped. In general, we believe that it will be most fruitful to study the effects of all of these mutations in combination with the har mutants described in this work. Evidence for suppression or enhancement of the halothane-resistance phenotype will help to arrange these genes as participants in one or more pathways affected by anesthetics.
